Association of gastric inhibitory polypeptide receptor (GIPR) gene polymorphism with type 2 diabetes mellitus in Iranian patients

Abstract

Abstract Introduction: Gastric inhibitory polypeptide receptor (GIPR) encodes a G-protein coupled receptor for gastric inhibitory polypeptide (GIP), which was demonstrated to stimulate insulin secretion. Relation of GIPR gene variation to type 2 diabetes mellitus has been suggested in previous studies. The aim of the study was to investigate single nucleotide polymorphisms (SNPs) in the promoter and coding regions of GIPR in type 2 diabetes mellitus (T2DM). Materials and methods Two hundred subjects including 100 healthy and 100 T2DM patients were recruited in the study. Genotypes and allele frequency of rs34125392, rs4380143 and rs1800437 in the promoter, 5ʹ UTR and coding region of GIPR were investigated by RFLP-PCR and Nested-PCR. Results Our finding indicated that rs34125392 genotype distribution was statistically different between T2DM and healthy groups (P = 0.043). In addition, distribution of T/- + -/- versus TT was significantly different between the both groups (P = 0.021). Moreover, rs34125392 T/- genotype increased the risk of T2DM (OR = 2.68, 95%CI = 1.203–5.653, P = 0.015). However, allele frequency and genotype distribution of rs4380143 and rs1800437 were not statistically different between the groups (P > 0.05). Conclusion We concluded that GIPR gene polymorphism is associated with T2DM.In addition; rs34125392 heterozygote genotype may increase the risk of T2DM. More studies with large sample size in other populations are recommended to show the ethnical relation of these polymorphisms to T2DM.